Evaluation of rosuvastatin-induced QT prolongation risk using real-world data, in vitro cardiomyocyte studies, and mortality assessment.
Sci Rep
; 13(1): 8108, 2023 05 19.
Article
in En
| MEDLINE
| ID: mdl-37208484
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Long QT Syndrome
/
Induced Pluripotent Stem Cells
Type of study:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Sci Rep
Year:
2023
Document type:
Article
Country of publication:
United kingdom